Oxaliplatin is a member of a group of drugs called alkylating agents, which are a type of chemotherapy

Fingolimod is known as the first oral drug to receive FDA approval for the control of multiple sclerosis (MS) symptoms

Lenalidomide is an anti-angiogenic drug and is an immune system regulator with strong anti-neoplastic, anti-angiogenic and anti-inflammatory properties

Anagrelide hydrochloride is a phosphodiesterase-III inhibitor that reduces the hydrolysis of cyclic adenosine monophosphate (Cyclic AMP) and subsequently increases its intracellular concentration